36 related articles for article (PubMed ID: 37244254)
1. Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial.
Shah MA; Shitara K; Ajani JA; Bang YJ; Enzinger P; Ilson D; Lordick F; Van Cutsem E; Gallego Plazas J; Huang J; Shen L; Oh SC; Sunpaweravong P; Soo Hoo HF; Turk HM; Oh M; Park JW; Moran D; Bhattacharya P; Arozullah A; Xu RH
Nat Med; 2023 Aug; 29(8):2133-2141. PubMed ID: 37524953
[TBL] [Abstract][Full Text] [Related]
2. Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism.
Yang X; Wang Z; Zandkarimi F; Liu Y; Duan S; Li Z; Kon N; Zhang Z; Jiang X; Stockwell BR; Gu W
Cell Metab; 2023 Aug; 35(8):1474-1490.e8. PubMed ID: 37467745
[TBL] [Abstract][Full Text] [Related]
3. Gastric cancer treatment: recent progress and future perspectives.
Guan WL; He Y; Xu RH
J Hematol Oncol; 2023 May; 16(1):57. PubMed ID: 37245017
[TBL] [Abstract][Full Text] [Related]
4. MTHFD2-mediated redox homeostasis promotes gastric cancer progression under hypoxic conditions.
Mo HY; Wang RB; Ma MY; Zhang Y; Li XY; Wen WR; Han Y; Tian T
Redox Rep; 2024 Dec; 29(1):2345455. PubMed ID: 38723197
[TBL] [Abstract][Full Text] [Related]
5. Ferroptotic therapy in cancer: benefits, side effects, and risks.
Diao J; Jia Y; Dai E; Liu J; Kang R; Tang D; Han L; Zhong Y; Meng L
Mol Cancer; 2024 May; 23(1):89. PubMed ID: 38702722
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis and its role in gastric and colorectal cancers.
Hou J; Wang B; Li J; Liu W
Korean J Physiol Pharmacol; 2024 May; 28(3):183-196. PubMed ID: 38682167
[TBL] [Abstract][Full Text] [Related]
7. Editorial: Multi-omics analysis of programmed cell death-mediated tumor microenvironment heterogeneity.
Jiang Y
Front Oncol; 2024; 14():1265418. PubMed ID: 38595819
[No Abstract] [Full Text] [Related]
8. Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.
Zhou Q; Meng Y; Li D; Yao L; Le J; Liu Y; Sun Y; Zeng F; Chen X; Deng G
Signal Transduct Target Ther; 2024 Mar; 9(1):55. PubMed ID: 38453898
[TBL] [Abstract][Full Text] [Related]
9. Toward a Unifying Hypothesis for Redesigned Lipid Catabolism as a Clinical Target in Advanced, Treatment-Resistant Carcinomas.
Bingham PM; Zachar Z
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762668
[TBL] [Abstract][Full Text] [Related]
10. Uncovering the IL-1β-PCAF-NNT axis: A new player in ferroptosis and tumor immune evasion.
Li Q; Gan B
Cancer Commun (Lond); 2023 Sep; 43(9):1048-1050. PubMed ID: 37488943
[No Abstract] [Full Text] [Related]
11. Nicotinamide nucleotide transhydrogenase-mediated redox homeostasis promotes tumor growth and metastasis in gastric cancer.
Li S; Zhuang Z; Wu T; Lin JC; Liu ZX; Zhou LF; Dai T; Lu L; Ju HQ
Redox Biol; 2018 Sep; 18():246-255. PubMed ID: 30059901
[TBL] [Abstract][Full Text] [Related]
12. Saturated Fatty Acid Activates T Cell Inflammation Through a Nicotinamide Nucleotide Transhydrogenase (NNT)-Dependent Mechanism.
McCambridge G; Agrawal M; Keady A; Kern PA; Hasturk H; Nikolajczyk BS; Bharath LP
Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30823587
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial NAD(P)
Francisco A; Figueira TR; Castilho RF
Antioxid Redox Signal; 2022 May; 36(13-15):864-884. PubMed ID: 34155914
[No Abstract] [Full Text] [Related]
14. Regulation of immune cell function by nicotinamide nucleotide transhydrogenase.
Regan T; Conway R; Bharath LP
Am J Physiol Cell Physiol; 2022 Apr; 322(4):C666-C673. PubMed ID: 35138175
[TBL] [Abstract][Full Text] [Related]
15. IL-1β-associated NNT acetylation orchestrates iron-sulfur cluster maintenance and cancer immunotherapy resistance.
Han Y; Zhang YY; Pan YQ; Zheng XJ; Liao K; Mo HY; Sheng H; Wu QN; Liu ZX; Zeng ZL; Yang W; Yuan SQ; Huang P; Ju HQ; Xu RH
Mol Cell; 2023 Jun; 83(11):1887-1902.e8. PubMed ID: 37244254
[TBL] [Abstract][Full Text] [Related]
16. A spontaneous mutation in the nicotinamide nucleotide transhydrogenase gene of C57BL/6J mice results in mitochondrial redox abnormalities.
Ronchi JA; Figueira TR; Ravagnani FG; Oliveira HC; Vercesi AE; Castilho RF
Free Radic Biol Med; 2013 Oct; 63():446-56. PubMed ID: 23747984
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
